During the last 16 years, we have resected small hepatocellular carcinomas (HCCs) measuring 5 cm or less from 362 patients, 266 of whom also had liver cirrhosis. The operative and hospital mortality rate were 1.7% and 1.9%, respectively. These showed a gradual decrease year by year in parallel with reduction of intraoperative blood loss achieved…
Seminars in Surgical Oncology Template
Write in a clean editor, then format for Seminars in Surgical Oncology in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Seminars in Surgical Oncology format
Seminars in Surgical Oncology is a peer-reviewed journal published by Wiley, covering Gastric Cancer Management and Outcomes, Sarcoma Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Seminars in Surgical Oncology 12 (3): 45–58.
Formats any DOI in Seminars in Surgical Oncology style. No sign-up. |
| Publishes research in | Gastric Cancer Management and Outcomes Sarcoma Diagnosis and Treatment Hepatocellular Carcinoma Treatment and Prognosis Pancreatic and Hepatic Oncology Research Colorectal Cancer Surgical Treatments |
| ISSN | 1098-2388 |
| h-index | 77 |
| i10-index | 654 |
| Total citations | 30,721 |
| Top institutions publishing here | Memorial Sloan Kettering Cancer Center |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Seminars in Surgical Oncology per year
Citation impact of Seminars in Surgical Oncology by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Seminars in Surgical Oncology
Ovarian cancer varies widely in frequency among different geographic regions and ethnic groups, with a high incidence in Northern Europe and the United States, and a low incidence in Japan. The majority of cases are sporadic, and only 5% to 10% of ovarian cancers are familial. The etiology of ovarian cancer is poorly understood. Models…
The prognostic impact of FIGO stage, histology, histologic grade, age and race in survival for cancers of the female gynecological (cervix, endometrium, ovary, vulva, vagina) were examined using cases obtained from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program that were diagnosed between 1973 and 1987. Utilizing Cox proportional hazards modeling and…
Intraperitoneal chemotherapy and cytoreductive surgery have been combined to reach treatment objectives in patients with peritoneal carcinomatosis or sarcomatosis that neither modality by itself can achieve. These treatments must be combined with the proper selection of patients in order to observe "high value" results from therapy. There are three principles of management to support treatments…
The incidence of bladder cancer continues to increase, with an estimated 53,000 new cases diagnosed in the United States in 1996-90% of which are transitional cell carcinomas. The male-to-female ratio is 3:1. A number of etiological factors are associated with the development of bladder cancer, but in industrialized countries, cigarette smoking is the most important.…